WEATHER ALERT

A coastal flood statement in effect for 2 regions in the area

Kimberly-Clark buying Tylenol maker Kenvue in $48.7 billion deal

By MICHELLE CHAPMAN
Associated Press

Associated Press

Published: 

Tylenol Lawsuit FILE - Tylenol pain relief products are shown on a store shelf in Carmel, Ind., Sept. 23, 2025. (AP Photo/Michael Conroy, file) (Copyright 2025 The Associated Press. All rights reserved.) (Michael Conroy/AP)

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a massive consumer health goods company.

Kenvue shareholders will receive $3.50 per share in cash and 0.14625 Kimberly-Clark shares for each Kenvue share held at closing. That amounts to $21.01 per share, based on the closing price of Kimberly-Clark shares on Friday.

Kimberly-Clark shareholders are expected to own about 54% of the combined company. Kenvue shareholders will own about 46%.

The deal is expected to close in the second half of next year. It still needs approval from shareholders of both both companies.

Copyright 2025 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed without permission.

About The Author